The preclinical proof of concept of translation projects.
During this webinar, Thomas Hanke, EVP Head of Academic Partnerships at Evotec in Germany, will present his vision and experience on how the preclinical validation of translational academic research projects should be planned and executed, in relationship with its foreseen clinical applications.
Evotec is a biotechnology company that offers technological expertise to advance drug discovery and development in a co-creation model with pharmaceutical companies, biotechs, foundations, and government agencies; as well as CRO/CDMO services for the Biopharma R&D sector.
This webinar is organised by the BioMedical SIG. Join the BioMedical SIG to stay informed.
